STME (Stimcell Energetics) Scaled Net Operating Assets: -17.46 (As of Feb. 2026)


STME Stimcell Energetics Inc STME
25 GF Score
Price $0.35
! 4 Warning Signs
View Full Analysis

What is Stimcell Energetics Scaled Net Operating Assets?

Stimcell Energetics STME +0.57% 25 Scaled Net Operating Assets is -17.46 as of Feb. 2026. GuruFocus rates STME with a GF Score™ of 25/100. The stock has 4 warning signs investors should review.

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Stimcell Energetics's operating assets for the quarter that ended in Feb. 2026 was $0.03 Mil. Stimcell Energetics's operating liabilities for the quarter that ended in Feb. 2026 was $0.93 Mil. Stimcell Energetics's Total Assets for the quarter that ended in Nov. 2025 was $0.05 Mil. Therefore, Stimcell Energetics's scaled net operating assets (SNOA) for the quarter that ended in Feb. 2026 was -17.46.

Stimcell Energetics Scaled Net Operating Assets Historical Data

* Premium members only.

The historical data trend for Stimcell Energetics's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Stimcell Energetics Scaled Net Operating Assets Chart

Stimcell Energetics Annual Data
Trend May16 May17 May18 May19 May20 May21 May22 May23 May24 May25
Scaled Net Operating Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only -8.15 -27.23 -36.17 -5.41 -17.46

Stimcell Energetics Quarterly Data
May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24 Feb25 May25 Aug25 Nov25 Feb26
Scaled Net Operating Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -18.40 -47.24 -39.48 -55.69 -17.46

STME vs BMRA, NVNO, TNON: Scaled Net Operating Assets Comparison

For the Medical Devices subindustry, Stimcell Energetics's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Stimcell Energetics Scaled Net Operating Assets vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Stimcell Energetics's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where Stimcell Energetics's Scaled Net Operating Assets falls into.


STME
25GF Score
Stimcell Energetics Inc STME
Scaled Net Operating Assets is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Stimcell Energetics Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Stimcell Energetics's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in May. 2025 is calculated as

Scaled Net Operating Assets (SNOA)(A: May. 2025 )
=(Operating Assets (A: May. 2025 )-Operating Liabilities (A: May. 2025 ))/Total Assets (A: May. 2024 )
=(0.006-0.809)/0.046
=-17.46

where

Operating Assets(A: May. 2025 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=0.021 - 0.015
=0.006

Operating Liabilities(A: May. 2025 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=1.268 - 0 - 0.459
=0.809

Stimcell Energetics's Scaled Net Operating Assets (SNOA) for the quarter that ended in Feb. 2026 is calculated as

Scaled Net Operating Assets (SNOA)(Q: Feb. 2026 )
=(Operating Assets (Q: Feb. 2026 )-Operating Liabilities (Q: Feb. 2026 ))/Total Assets (Q: Nov. 2025 )
=(0.025-0.933)/0.052
=-17.46

where

Operating Assets(Q: Feb. 2026 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=0.035 - 0.01
=0.025

Operating Liabilities(Q: Feb. 2026 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=1.713 - 0.769 - 0.011
=0.933

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Scaled Net Operating Assets of -17.46 mean?
Stimcell Energetics (STME) has a Scaled Net Operating Assets of -17.46 as of Feb. 2026. Scaled net operating assets equals current-period operating assets less operating liabilities less prior-period total assets. View historical data on Stimcell Energetics and its competitors.
Is Stimcell Energetics' Scaled Net Operating Assets too high?
Stimcell Energetics' current Scaled Net Operating Assets is -17.46. Overall, Stimcell Energetics has a GF Score™ of 25/100, reflecting its overall financial health beyond just this single metric.
How does Stimcell Energetics' Scaled Net Operating Assets compare to BMRA and NVNO?
Stimcell Energetics' Scaled Net Operating Assets of -17.46 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Scaled Net Operating Assets for a Medical Devices & Instruments company?
A good Scaled Net Operating Assets depends on the Medical Devices & Instruments industry context. However, Scaled Net Operating Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Scaled Net Operating Assets mean?
A high Scaled Net Operating Assets can signal that a stock is expensive relative to its fundamentals. Scaled net operating assets equals current-period operating assets less operating liabilities less prior-period total assets. View historical data on Stimcell Energetics and its competitors. Stimcell Energetics's current Scaled Net Operating Assets is -17.46. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Stimcell Energetics stock overvalued right now?
Stimcell Energetics (STME) has a current Scaled Net Operating Assets of -17.46. The current Scaled Net Operating Assets is -17.46. Stimcell Energetics' overall GF Score™ is 25/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Scaled Net Operating Assets calculated?
Scaled Net Operating Assets is calculated from a company's financial statements. For Stimcell Energetics (STME), the current Scaled Net Operating Assets is -17.46 as of Feb. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Stimcell Energetics Business Description

Address 1130 Pender Street, West, Suite 820, Vancouver, BC, CAN, V6E 4A4
Stimcell Energetics Inc is a biotech company focused on the discovery, development, and commercialization of therapeutic and non-therapeutic products that enhance cellular function, promote general wellness, and alleviate health complications, including, but not limited to: aging, diabetes, high blood pressure, neuropathy, and kidney function. The company's main focus is on continued research and development of its eBalance Technology and its eBalance Home System.
25GF Score

Get the complete analysis for STME

Scaled Net Operating Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.35
Price